Laura Samá

📣 Abstract submission is OPEN! Join us at the ESMO Sarcoma and Rare Cancers Congress 2026 in Lugano, 12–14 March. ⏰ Abstract submission ddl: 9 December, 21:00 CET. 👉 Don’t miss your chance to present at this global oncology forum! #ESMORareCancers26 🔗 ow.ly/VXqA50WVzYH

Follow us! @oncoteamsarcoma

🔎 Demicco Score in Solitary Fibrous Tumors (SFT): A practical, pathology-based tool to assess metastatic risk in primary SFTs. 3-variable (2012): Size, Mitoses, Age 4-variable (2017): + Necrosis 🧠 Do you use it in your practice? #Sarcoma #SFT #OncoPath

🚨 Opportunity for early-career surgical oncologists! Apply for the SSO-ESSO ICDE 2026 and: ✈️ Attend #SSO2026 in Phoenix 🏥 Join a 1-week US clinical observership 🤝 Get matched with a long-term SSO mentor 🔗 Apply by 30 Sept 2025: essoweb.org/fellowships/ss…

We're launching a new series #fromCTOStoSUCCESS to highlight papers based on data presented at #CTOS2024! 🚨New benchmark values for outcomes of comprehensive resection of retroperitoneal liposarcoma! Great effort by @TirottaFabio and @TARPSWG collaborators👏 link below⬇️

‼️ Pelvic Sarcoma A Solitary Fibrous Tumor managed at the Sarcoma Surgery Unit, ⁦@HumanitasMilano⁩ (Dir. ⁦@FCMCananzi⁩ ). #SarcomaSurgery #Teamwork #SICOSarcomaSocial #SurgicalOncology #RareTumors

For more information: 🔗 eortcresearchfund.org/soft-tissue-bo… 🔗 eortc.org/blog/2020/04/2… @WinanvanHoudt @alegronchi #CancerResearch #Sarcoma #ClinicalTrials #Oncology #Surgery

Could neoadjuvant chemo reshape RPS treatment? #STRASS2 is testing if pre-op chemo improves outcomes in high-risk DDLPS & LMS. A game-changing randomized phase III trial in the making. 🧵👇 Like, Share and Comment! #SarcomaSurgery #SICOSarcomaSocial #ClinicalTrials

🚨 #STRASS trial & neoadjuvant RT in RPS: where do we stand? 📚 No ARFS benefit overall 📈 Signals in liposarcoma Your take on preop RT for low-grade LPS? 👉 Follow @SICOSarcoma for more. #SarcomaSurgery #RetroperitonealSarcoma @ctosociety @TARPSWG @ItaSarcomaGroup @ESSOnews

CTOS President @SilviaStacchia is inviting everyone to join the Annual Meeting in Boca Raton and celebrate 30th Anniversary of the Society! Get ready and prepare your abstracts! Especially on the #sarcoma of the year 🌟#chondrosarcoma #CTOS2025 #CTOSTweeTOS

Excellent and comprehensive review on management of retroperitoneal sarcomas. Well done!

Exploring #MIS solutions for #duodenal #GIST? Take a look at our approach to Laparoscopic #Pancreas-Preserving Duodenal Resection: link.springer.com/10.1245/s10434… @alegronchi @AnnSurgOncol @FioreDoc @IstTumori @ItaSarcomaGroup @oncoteamsarcoma #surgery #surgicaloncology

Thrilled to share our latest publication in @AnnSurgOncol Practice Guideline Series: Multidisciplinary management of #retroperitoneal #sarcoma Full text 🔗: rdcu.be/elqzw Thank you @kencardonaMD @DCalleMD for your incredible partnership and expertise

📌 Clinical Case 3 This case dives into #neoadjuvant #treatment for retroperitoneal sarcoma. Why did we opt for #radiotherapy before surgery? Clue: STRASS trial 👇 🫱 Acknowledgment for imaging: Istituto Oncologico Europeo (IEO), Milan. #Sarcoma #RPS #SICOSarcomaSocial

New Q&A session! All answers are evidence-based! Must-read papers: 🔗pubmed.ncbi.nlm.nih.gov/33740198/ 🔗pubmed.ncbi.nlm.nih.gov/40152715/ 🔗 pubmed.ncbi.nlm.nih.gov/31159625/

Impact and safety of pregnancy on desmoid fibromatosis management in the era of active surveillance. An international multicenter retrospective observational study - European Journal of Cancer ejcancer.com/article/S0959-…

Are you following our SICO Sarcoma Social Journal Club? 🙋🙋‍♀️🙋‍♂️If you have any questions or doubts, feel free to leave a comment or send us a DM. We will address all your questions next week during the Q&A session!

@GladdyLab @TARPSWG

@Dirk_Strauss @TARPSWG

@FioreDoc @TARPSWG